BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis
Europe - EPA:ALTUV - FR0013345493 - Common Stock
1.592 EUR
-0.05 (-2.93%)
Overall ALTUV gets a fundamental rating of 4 out of 10. We evaluated ALTUV against 109 industry peers in the Machinery industry. ALTUV has an average financial health and profitability rating. ALTUV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ALTUV had positive earnings in the past year.
ALTUV had a positive operating cash flow in the past year.
ALTUV had positive earnings in each of the past 5 years.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
1.2 Ratios
ALTUV has a Return On Assets of 1.36%. This is in the lower half of the industry: ALTUV underperforms 60.91% of its industry peers.
With a Return On Equity value of 2.41%, ALTUV is not doing good in the industry: 64.55% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.84%, ALTUV is doing worse than 69.09% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALTUV is below the industry average of 8.90%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROIC | 2.84% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
1.3 Margins
ALTUV has a Profit Margin (2.64%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ALTUV has declined.
ALTUV has a Operating Margin of 5.93%. This is comparable to the rest of the industry: ALTUV outperforms 50.00% of its industry peers.
ALTUV's Operating Margin has improved in the last couple of years.
ALTUV has a Gross Margin of 38.14%. This is comparable to the rest of the industry: ALTUV outperforms 48.18% of its industry peers.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% |
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
2. Health
2.1 Basic Checks
ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ALTUV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALTUV has more shares outstanding
ALTUV has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.45, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.45, ALTUV is not doing good in the industry: 62.73% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALTUV is 7.69, which is on the high side as it means it would take ALTUV, 7.69 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.69, ALTUV perfoms like the industry average, outperforming 44.55% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
ALTUV has a Debt to Equity ratio (0.39) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Altman-Z | 1.45 |
ROIC/WACC0.41
WACC6.99%
2.3 Liquidity
A Current Ratio of 2.05 indicates that ALTUV has no problem at all paying its short term obligations.
ALTUV has a Current ratio of 2.05. This is in the better half of the industry: ALTUV outperforms 80.00% of its industry peers.
A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV's Quick ratio of 1.31 is fine compared to the rest of the industry. ALTUV outperforms 79.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
ALTUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 195.24%, which is quite impressive.
The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
The Revenue has decreased by -7.99% in the past year.
ALTUV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.65% yearly.
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
3.2 Future
Based on estimates for the next years, ALTUV will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.51% on average per year.
The Revenue is expected to grow by 3.57% on average over the next years.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.74 indicates a rather expensive valuation of ALTUV.
ALTUV's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ALTUV to the average of the S&P500 Index (26.06), we can say ALTUV is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 15.46, the valuation of ALTUV can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALTUV is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.73, ALTUV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.74 | ||
| Fwd PE | 15.46 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALTUV.
ALTUV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALTUV is cheaper than 80.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.2 | ||
| EV/EBITDA | 9.11 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%
5. Dividend
5.1 Amount
ALTUV has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.60, ALTUV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, ALTUV has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPA:ALTUV (11/7/2025, 7:00:00 PM)
1.592
-0.05 (-2.93%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners6.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.53M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (92.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)40%
EPS NY rev (3m)-64.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.74 | ||
| Fwd PE | 15.46 | ||
| P/S | 0.6 | ||
| P/FCF | 8.2 | ||
| P/OCF | 4.72 | ||
| P/B | 0.54 | ||
| P/tB | 4.39 | ||
| EV/EBITDA | 9.11 |
EPS(TTM)0.07
EY4.4%
EPS(NY)0.1
Fwd EY6.47%
FCF(TTM)0.19
FCFY12.19%
OCF(TTM)0.34
OCFY21.17%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROCE | 3.87% | ||
| ROIC | 2.84% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 7.55% | ||
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% | ||
| FCFM | 7.26% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Debt/EBITDA | 3.38 | ||
| Cap/Depr | 79.6% | ||
| Cap/Sales | 5.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.7% | ||
| Profit Quality | 275.52% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.45 |
F-Score7
WACC6.99%
ROIC/WACC0.41
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A
BIO-UV GROUP SAS / ALTUV.PA FAQ
Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.
What is the valuation status for ALTUV stock?
ChartMill assigns a valuation rating of 3 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Overvalued.
What is the profitability of ALTUV stock?
BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.
How financially healthy is BIO-UV GROUP SAS?
The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.
What is the earnings growth outlook for BIO-UV GROUP SAS?
The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.